Condition
Brain Damage, Chronic
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03625570Not ApplicableCompleted
Power Training Combined With Interval Treadmill Training
NCT01602276Not ApplicableTerminatedPrimary
The Effect of tDCS on Subcortical Brain Functioning
NCT02637817Unknown
MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates
NCT02810626Not ApplicableUnknownPrimary
DTI & Tractography in Pediatric Tumor Surgery
NCT00544895CompletedPrimary
Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants
Showing all 5 trials